Objective: We studied whether consumption of phenol-rich extra virgin olive oil affects the susceptibility of low density lipoproteins (LDL) to oxidation and other markers of oxidation in humans. Design: Randomized cross-over intervention trial, strati®ed according to sex, age and energy intake. Setting: Division of Human Nutrition and Epidemiology, Wageningen University, The Netherlands. Subjects: Forty-six healthy men and women completed the study. Intervention: Subjects consumed two diets supplying 69 g per day of extra virgin olive oil either rich or poor in phenols for 3 weeks each. The mean difference in phenol intake between the treatments was 18 mg per day. Vitamin E intake was low during the whole study. Fasting blood samples were taken twice at the end of each period. Results: Resistance of LDL and high density lipoprotein (HDL) to oxidation was not affected by treatment. The mean lag time of copper-induced formation of conjugated dienes was 1.6 min shorter in LDL and 0.4 min longer in HDL after the high phenol diet. Other markers of antioxidant capacity in plasma were also not affected: mean lipid hydroperoxides were 0.07 mmolal higher, mean malondialdehydes were 0.001 mmolal higher, mean protein carbonyls were 0.001 nmolamg protein lower, and the mean ferric reducing ability of plasma (FRAP) was 0.006 mmolal higher after the high phenol diet. All 95% con®dence intervals enclosed zero. Serum cholesterol concentrations were not affected by the treatment. 
Introduction
The Mediterranean diet, with olive oil as the major fat source, has been shown in epidemiological studies to be associated with a reduced incidence of coronary heart disease (Keys et al, 1986) . The replacement of dietary saturated fatty acids with monounsaturated oleic acid from olive oil decreases plasma LDL concentrations, which presumably contributes to the low incidence of coronary heart diseases (Katan et al, 1995) . It has also been suggested that a high-monounsaturated fat diet lowers the risk of coronary heart disease by producing oleic acid-enriched LDL particles, which are more resistant to oxidative modi®cation (Bonanome et al, 1992; Reaven et al, 1991; Aviram & Eias, 1993) . Oleic acid, however, may not be the only component of olive oil protecting LDL from oxidation; some types of extra virgin olive oil contain phenols with antioxidative properties. These phenols are formed during ripening of olives by hydrolysis of the parent compound oleuropein (Figure 1 ), and they are, in contrast to phenols from, for example tea and wine, partly lipidsoluble.
The oxidative modi®cation hypothesis of atherosclerosis suggests that LDL particles are oxidatively modi®ed and then taken up by macrophages inside the arterial wall. Such cholesterol-laden macrophages form the start of athero-sclerotic plaques. Dietary antioxidants may therefore inhibit atherogenesis by inhibiting oxidation of LDL and accumulation of LDL in macrophages . When olive oil is ingested, the lipid-soluble phenols are possibly taken up by LDL particles in plasma. Thus, these phenols may protect LDL particles from becoming atherogenic by oxidative modi®cation. The aim of this study was to determine whether consumption of phenols from olive oil affects the susceptibility of LDL to oxidation and other markers of oxidation in normolipemic humans.
Subjects and methods

Subjects
Subjects were recruited via publicity in local newspapers and posters in university buildings and student apartments. We carefully explained the study protocol before subjects gave their written informed consent. The study protocol was approved by the Medical Ethical Committee of the Division of Human Nutrition and Epidemiology of Wageningen University.
Subjects were eligible if they were older than 17 y, did not use any drugs known to affect concentrations of serum lipids, were not pregnant, not lactating, and not on a prescribed diet. Volunteers ®lled out a medical questionnaire that was reviewed by an independent physician. Persons with a history of gastrointestinal, liver or kidney disease were excluded, as were those with glucosuria, proteinuria, anaemia, a serum concentration of total cholesterol b7.0 mmolal, or fasting triglycerides b2.3 mmolal, and serum values of liver enzymes b30 Ual for alanine aminotransferase (ALT), or b30 Ual for aspartate aminotransferase (AST). Thirty-two women and 17 men, 18 ± 58 y, were enrolled in the study. Three subjects withdrew during the study; one because of illness unrelated to the treatment, and two because of personal reasons. 
Effect of olive oil on markers of oxidation MN Vissers et al
Forty-six subjects completed the study. None of the subjects used medications that could have affected the results.
Design and treatment
The study consisted of two 3-week treatment periods, during which each subject consumed two diets, one with phenol-rich extra virgin olive oil and one with phenol-poor extra virgin olive oil, in random order (cross-over). Before the study subjects were strati®ed according to sex, age and energy intake and then randomly allocated to one of the two sequence groups. During the 2 weeks before the study (run-in) and 2 weeks in-between the treatment periods (wash-out) subjects consumed diets without olives, olive oil and olive oil products.
The high phenol olive oil was prepared from Tsunati olives with a high content of phenols. The low phenol olive oil was prepared from Koroneiki olives; most of the phenols were removed by washing with hot water. Vitamin E was added to the high phenol olive oil to obtain the same vitamin E content in both oils. The two olive oils had a similar fatty acid composition (data not shown). The phenol concentration in the experimental oils was determined as described by Montedoro et al (1993) . The high phenol olive oil contained 308 mgakg of phenols, of which 2% was tyrosol, 1% was hydroxytyrosol, 72% were oleuropeinaglycones, and 25% were ligstroside-aglycones. The low phenol olive oil contained 43 mgakg of phenols, of which 16% was tyrosol, 2% was hydroxytyrosol, 13% were oleuropein-aglycones, and 69% were ligstroside-aglycones. The mean difference in phenol intake between the high and low phenol diet was 18 mgaday.
Before the trial, energy intake of individual subjects was estimated by a food frequency questionnaire (Feunekes et al, 1993) . Each subject received the amount of olive oil that ful®lled energy needs. Energy intakes were subdivided into four levels, ranging from 7.5 to 17.5 MJ per day. The amount of olive oil per day varied from 55 to 102 g, with a mean intake of 69 g. Forty percent of the daily oil was incorporated into a mayonnaise (78 waw% olive oil), 30% was incorporated into sauces for hot meals, and 30% in cookies and raisin rolls baked by a local bakery. We recorded body weights twice weekly and adjusted the intake of olive oil when necessary so as to maintain a stable weight. Over the duration of the trial average body weight increased by 0.3 AE 0.9 kg (range À1.2 ± 2.8 kg). Body weight did not differ between treatments; it was 68.0 AE 9.6 kg on the high phenol diet, and 67.8 AE 9.5 kg on the low phenol diet.
Each study diet was assigned a colour code that was used for labelling all foods supplied during the trial. In this way, subjects were blinded to the type and the sequence of the olive oils. On weekdays at noon, hot meals were served and eaten at the department in the presence of the researchers. These meals supplied at least 50% of the experimental olive oil. Foods that contained the remaining part of the olive oil were consumed at home. Foods containing the experimental olive oil were weighed or counted for each subject. During the whole study subjects followed instructions for a background diet low in vitamin E. A margarine with a low vitamin E content was supplied (Van den Bergh Foods, UK). Apart from this, subjects were asked to maintain their usual diet. During the study subjects were not allowed to take vitamin supplements or aspirin, which is a radical scavenger (Kuhn et al, 1995; Hermann et al, 1999) . Therefore they were provided with acetaminophen (paracetamol). Subjects were asked to maintain their usual pattern of physical activity and not to change their smoking habits, consumption of coffee, or use of oral contraceptives. All subjects kept daily records of illness and deviations from the protocol. Diaries and anonymous questionnaires administered after the trial showed that consumption of experimental olive oil was 90% of the scheduled amount for the low phenol diet and 87% for the high phenol diet. To check adherence, we added 6.8 mmolag of lithium chloride to the mayonnaise. The daily intake of lithium was 190 ± 360 mmoladay, depending on the level of energy intake and consequently the amount of olive oil consumed per day. Mean plasma lithium concentrations after olive oil consumption was 4.7 AE 1.3 mmolal, which was about ®ve times the concentration of 0.9 AE 0.3 mmolal in similar subjects that did not consume added lithium chloride (De Roos et al, 2001 ). This con®rmed adherence of the subjects to the protocol.
Blood sampling
Venous blood samples were taken twice after a 12-h fast at the end of each 3-week period (days 17 and 21). Plasma or serum was immediately obtained by low speed centrifugation and stored at À80 C. For the determination of the concentration of serum lipids, the liver enzymes, uric acid and the ability of plasma to reduce iron (III) (FRAP), the two samples of each subject at the end of each period were analysed separately and the results were averaged before statistical analysis. For the determination of the susceptibility of LDL and HDL to oxidation, the two samples obtained at the end of each period were pooled before analytical analyses. For all other analyses, only the last samples obtained at the end of each period were used.
Lipoprotein isolation
Plasma lipoproteins were isolated by density gradients ultracentrifugation in a SW 41Ti rotor (Beckman Instruments, Palo Alto, USA) for 24 h at 10 C (Redgrave et al, 1975) . LDL was isolated in a density range of 1.019 ± 1.063 gaml, and HDL in a density range of 1.063 ± 1.210 gaml. Density gradients solutions contained 0.1 mM Na 2 EDTA to inhibit metal ion catalysed LDL and HDL oxidation during the isolation procedure.
Markers of oxidizability
The susceptibility of LDL and HDL to copper-mediated oxidation was determined by monitoring the formation of conjugated dienes, essentially as described by Princen et al (1992) . Malondialdehyde in plasma was determined as described by Wong et al (1987) , except that the HPLC eluent was monitored using¯uorescence detection. The excitation wavelength was 537 nm and the emission wavelength was 554 nm. Lipid hydroperoxides in plasma were determined by the K-Assay LPO-CC kit (Kamiya Biomedical Company, Seattle, WA USA). Protein carbonyls in plasma were determined by an ELISA method as described by Buss et al (1997) . The ability of plasma to reduce iron (III) (FRAP) was determined by the method of Benzie and Strain that measures the reduction of ferric to ferrous iron in the presence of antioxidants (Benzie & Strain 1996) .
Vitamin and uric acid concentrations in serum
The concentrations of lycopene, b-carotene, retinol and atocopherol in serum samples were determined by high performance liquid chromatography (HPLC, Waters Instruments, Milfort, USA). Serum was deproteinised with ethanol-internal standard solution (1X1 vav) and extracted with hexane. A part of the hexane layer was evaporated after centrifugation and reconstituted in the mobile phase. Samples to determine retinol and a-tocopherol were injected into a Resolve C 18 -5 mm column (30 cmÂ3.9 mm; Waters Instruments, Milfort, USA) with methanola dichloromethaneaacetonitrile (10X20X70, vav) as the mobile phase, with detection at 325 and 292 nm, respectively. Samples to determine lycopene and b-carotene were injected into a Sperisorb 5 mm ODS-2 column (25 cmÂ4.6 mm; Waters Instruments, Milfort, USA) with methanoladichloromethaneaacetonitrile (30X20X50, vav) as the mobile phase, with detection at 472 and 450 nm, respectively. Calibration was performed by a single standard solution on the same way as a sample. Serum uric acid was determined by UA plus kit (Boehringer, Mannheim, Germany).
Serum lipids and liver enzymes
Serum lipids were analysed enzymatically (Siedel et al, 1983; Warnick et al, 1982; Fossati & Prencipe, 1982) . Mean bias for control samples provided by the Centers of Disease Control in Atlanta was À1% for total and high density lipoprotein cholesterol and 10% for triglycerides.
The coef®cient of variation within runs ranged from 0.5 to 1.1%. Low density lipoprotein cholesterol concentrations were calculated (Friedewald et al, 1972) . Alanine and aspartate aminotransferase were measured at 37 C using Abbott Spectrum reagents (Bergmeyer et al, 1978) . The mean bias for`Monitrol' control sera (Baxter Dade, Switzerland) ranged from 0 to 2%. The coef®cient of variation within runs ranged from 2 to 8%.
Statistical analyses
The data were analysed by ANOVA using the General Linear Models (GLM) of the Statistical Analyses System (SAS Institute Inc., 1989). The Tukey method was used for calculation of 95% con®dence limits of the differences between the two diets.
Results
Markers of oxidizability
Resistance of LDL and HDL to copper-mediated oxidation and other markers of antioxidant capacity or oxidative processes were not affected by treatment (Table 1 ). The lag time of copper-induced formation of conjugated dienes was 1.6 min shorter in LDL and 0.4 min longer in HDL after the high phenol diet. Maximum rate of diene formation in LDL and HDL were similar after both treatments (Table 1) .
Other oxidation markers were also not affected. Plasma lipid hydroperoxides and malondialdehydes, both markers of lipid peroxidation, were respectively 0.07 and 0.001 mmolal higher after the high phenol diet. Protein carbonyls, a marker of protein oxidation in plasma, were 0.001 nmolamg protein lower after the high phenol diet. The ferric reducing ability of plasma (FRAP), a marker for the antioxidant capacity of plasma, was 0.006 mmolal higher after the high phenol diet. All 95% con®dence intervals enclosed zero (Table 1) . Vitamin and uric acid concentrations in serum Serum uric acid, lycopene, retinol, b-carotene or a-tocopherol was not affected by the treatment (Table 2) . The concentration of a-tocopherol in our subjects was 19.4 AE 5.0 mmolal, which is relatively low compared to normal plasma vitamin E concentrations from 11 to 37 mmolal (Cohn, 1997) . This can be explained by the low vitamin E content in the diet. This suggested adherence of the subjects to the protocol.
Serum lipids and liver enzymes
Mean total cholesterol was 0.06 mmolal lower (not signi®-cant) on the high phenol diet than on the low phenol diet. Concentrations of LDL, HDL, triglycerides and the liver enzymes alanine and aspartate aminotransferase also did not differ between the high and low phenol diet (Table 3 ).
Discussion
Our data show that consumption of 18 mg per day of phenols from olive oil for 3 weeks does not affect in vitro susceptibility of LDL to oxidation or other markers of oxidation in fasting blood of healthy volunteers. Our results are in line with two other human studies that addressed the effect of minor components in olive oil on the susceptibility of LDL to oxidation in fasting blood (Nicolaõ Èew et al, 1998; Bonanome et al, 2000) . In these studies, extra virgin olive oil vs high oleic acid sun¯ower oil or re®ned olive oil also did not affect the in vitro susceptibility of LDL to oxidation in fasting plasma samples. Other human studies on the effect of olive oil on LDL oxidation addressed the effects of oleic acid rather than olive oil phenols per se (Reaven et al, 1991; Bonanome et al, 1992; Tsimikas et al, 1999) . In vitro, the olive oil phenols hydroxytyrosol and oleuropein strongly inhibited LDL oxidation (Visioli et al, 1995; Visioli & Galli, 1994) . Also, tyrosol, oleuropein and extracts of minor components from extra virgin olive oil decreased the oxidation of LDL as assessed by oxysterol formation (Berra et al, 1995; Caruso et al, 1999) . We realise that LDL oxidation ex vivo is different from LDL oxidation in vitro. Phenols or antioxidants might get lost during isolation of LDL from plasma by centrifugation, a process that is absent when doing experiments in vitro. However, in rabbits and rats, non-tocopherol antioxidants from olive oil showed a favourable effect on the susceptibility of LDL to oxidation (Wiseman et al, 1996; Coni et al, 2000; Scaccini et al, 1992) . This suggests that during isolation phenols might stay in or attached to lipoprotein particles where they might affect the resistance of LDL to oxidation. Thus, results of animal and in vitro studies suggest a protective effect of phenols from olive oil on LDL oxidation, but such an effect was not observed in fasting blood samples of humans in the Effect of olive oil on markers of oxidation MN Vissers et al present and other studies (Nicolaõ Èew et al, 1998; Bonanome et al, 2000) . One explanation might be that our study did not address postprandial effects. If phenol clearance is fast, phenol concentrations might be elevated in the ®rst hours after a meal and during that time protect LDL from oxidation, but not after 12 h of fasting as in our study. Visioli et al actually found that the phenols tyrosol and hydroxytyrosol were mostly excreted within 24 h after intake of 50 ml extra virgin olive oil, which indicates that clearance of phenols from plasma is fast (Visioli et al, 2000) . Furthermore, Bonanome et al found a signi®cant postprandial effect 2 h after intake of 100 g of extra virgin olive oil on plasma antioxidant capacity, but they did not include a control group (Bonanome et al, 2000) . Nicolaõ Èew et al, on the other hand, did not ®nd a signi®cant effect on the lag time or maximum rate of LDL oxidation of extra virgin olive oil 6 h after intake (Nicolaõ Èew et al, 1998) . The proper study of postprandial effects requires more insight into the kinetics of phenol transport and metabolism in man and more studies are needed on this aspect.
We also did not ®nd an effect of phenols from extra virgin olive oil on the susceptibility of HDL to oxidation. Like modi®ed LDL, oxidatively modi®ed HDL is suggested to increase intracellular cholesterol accumulation (Nagano et al, 1991; Gesquiere et al, 1997; BonnefontRousselot et al, 1995) . The physiological role of HDL oxidation is still unclear, but in our study 18 mg of phenols per day for 3 weeks did not in¯uence the susceptibility of HDL to oxidation in fasting plasma samples.
Furthermore, we did not ®nd an effect of olive oil phenols on other plasma markers of lipid and protein oxidation (lipid hydroperoxides, malondialdehyde, protein carbonyls and FRAP). The average plasma values of the oxidation markers in our study were in line with those found in other studies. Lag time of LDL oxidation was about 110 min, which is relatively high (Esterbauer & Ju Èrgens, 1993) . This can be explained by methodological differences and the high dose of oleic acid that increases the resistance of LDL to oxidative modi®cation (Bonanome et al, 1992; Reaven et al, 1991; Tsimikas et al, 1999) . Mean plasma lipid hydroperoxide and malondialdehyde concentrations and FRAP were similar to values found by others (Wong et al, 1987; Benzie & Strain, 1996) . Protein carbonyls were slightly higher in our subjects than in healthy subjects in the study by Buss et al, but much lower than in 23 critically ill subjects in the same study (Buss et al, 1997) . Thus, plasma values of the markers of oxidation were within previously reported ranges.
The phenol oleuropein-aglycone and some of its derivatives (Figure 1 ) from extra virgin olive oil are lipidsoluble, while oleuropein, tyrosol and hydroxytyrosol are water-soluble (Unilever Research Vlaardingen, unpublished data). We therefore hypothesised that the lipidsoluble aglycones, which are the main phenols in olive oil, may accumulate in LDL and HDL particles and provide better protection of LDL against oxidation than other, more water-soluble, dietary compounds like phenols from tea and wine, for example. The amount of phenols needed to protect LDL and HDL from oxidation is unknown. Also, data about the amounts of other antioxidants needed to protect LDL from oxidation are scarce. Vitamin E is the most important lipid-soluble antioxidant in the body Jialal et al, 1995) . In one dose ± response study Princen et al suggested that intake of 25 mgaday of vitamin E for 2 weeks was suf®cient to reduce the susceptibility of LDL to oxidation (Princen et al,1995) . In another dose ± response study, Jialal et al investigated the effects of vitamin E intake in doses of 60, 200, 400, 800 and 1200 mgaday. They found that at least 400 mgaday of vitamin E was needed to reduce the susceptibility of LDL to oxidation (Jialal et al, 1995) . Thus, the minimum dose of vitamin E needed to reduce the susceptibility of LDL to oxidation is as yet unclear. However, if 25 mgaday of vitamin E is the minimum effective amount and if olive oil phenols and vitamin E would be equally effective, then the amount of 18 mgaday in our study might have been too low to detect an effect on LDL oxidizability. Moreover, vitamin E might partition better into LDL particles and thus be more effective in reducing the susceptibility of LDL to oxidation then phenols from olive oil. This implies that even more dietary phenols would be needed to detect an effect. Thus, the amount of 18 mgaday of olive oil phenols in our study, a very high intake in terms of practical realistic diets, might have been too low to affect LDL oxidizability.
More is known about the in vitro than about the in vivo antioxidant activity of olive oil phenols. In vitro dose ± response studies by Visioli and co-workers demonstrated that pre-incubation of LDL with 10 mmolal oleuropein or 10 mmolal hydroxytyrosol inhibited the decrease of vitamin E in LDL during copper-mediated oxidation and delayed the formation of conjugated diene formation, lipid peroxides and thiobarbituric acid-reacting substances (Visioli et al, 1995; Visioli & Galli, 1994) . These studies showed that the protection of vitamin E from oxidation was correlated with the concentration of oleuropein or hydroxytyrosol, and that a concentration of 1 mmolal provided much less protection than a concentration of 10 mmolal (Visioli et al, 1995; Visioli & Galli, 1994) . Visioli et al suggested that olive oil phenols retard the oxidation of the natural vitamin E pool in LDL and in this way indirectly protect LDL from oxidation. We do not know the plasma concentration of the various phenols that were reached in our study, but it is unlikely that it reached 1 mmolal after a whole-body dose of 18 mg (about 50 mmol) per day for 3 weeks. Thus, on the basis of in vitro data the concentration of phenols in LDL was probably too low to produce detectable effects on LDL oxidizability.
It remains possible that amounts of olive oil phenols higher than the 18 mgaday fed in our study can affect LDL oxidizability. However, we supplied the maximum dose that is achievable with practical every-day diets. Olives were specially selected to obtain a large difference in phenol concentration between the experimental oils, and the subjects consumed large amounts of olive oil (69 gaday). The average daily intake of phenols from olive oil is not exactly known, but estimations from the Mediterranean diet indicate that 10 ± 20 mgaday of total phenols may be supplied by olive oil (Visioli et al, 1995) . According to our data, this is probably not enough to affect markers of antioxidant status in fasting plasma samples.
It is conceivable that the background diet of our subjects contained too high an amount of antioxidants to allow additional antioxidant effects of the phenols of extra virgin olive oil. Our subjects consumed a background diet low in vitamin E, which was con®rmed by the low plasma vitamin E concentrations. Furthermore, subjects were not allowed to take vitamin supplements. However, it is possible that tissue stores of vitamin C and vitamin E for example, after the run-in period were still considerable, and it may require depletion periods to show an effect. Thus, olive oil might theoretically still affect oxidizability of fasting LDL in subjects who are depleted in dietary antioxidants.
The oxidative modi®cation hypothesis of atherosclerosis is an attractive one, but it is still not proven that dietary antioxidants prevent coronary heart disease (Zock & Katan, 1998) . Only a few studies have reported the relation between markers of oxidation and coronary heart disease, and the results of these studies are inconsistent (Van de Vijver et al, 1998; de Rijke et al, 1995; Cominacini et al, 1993; Croft et al, 1992) . Thus, none of the oxidation markers have yet been validated as risk factors for atherosclerosis, although it may be that markers more representative of in vivo changes, like oxidised LDL antibodies, may be more sensitive to changes in LDL antioxidant content. Much work remains to be done here. In addition, randomised clinical trials with hard endpoints are needed to prove that dietary antioxidants, such as the phenols from olive oils, may offer protection against coronary heart disease.
The serum concentrations of total and LDL cholesterol did not differ between the two diets. It has been suggested that minor components, such as phenols, may be responsible for a cholesterol-lowering effect (Matsumoto et al, 1998) . We therefore studied the effects of olive oil phenols on serum cholesterol concentrations. Our results are in line with those of Nicolaõ Èew et al, who found that a diet with extra virgin olive oil and a diet with oleic-acid-rich sunower oil produced the same cholesterol concentrations (Nicolaõ Èew et al, 1998) . Thus, the cholesterol-lowering effect of olive oil is probably not due to its phenolic compounds.
We also measured the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Phenols from extra virgin olive oil are responsible for the bitter taste of extra virgin olive oil. This bitter taste might be a warning from nature for possible adverse or toxic effects. We therefore measured ALT and AST as indicators of such effects. In our study the serum concentrations of ALT and AST did not differ between the two diets. This suggests that phenols from olive oil have no adverse affects on liver integrity.
In conclusion, we did not ®nd an effect of a high intake of phenol-rich olive oil on the susceptibility of LDL and HDL to oxidation and other markers of oxidation in fasting plasma. The natural concentration of phenols in olive oil might be too low or their clearance from plasma too fast to produce an effect on markers of oxidation in the postabsorptive phase.
